SCHEMBL14848544

SCHEMBL14848544

COC(=O)Cc1cc(-c2ccccc2)oc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HPGD P15428 5/20 0.44
KDM4E B2RXH2 5/20 0.44
HSD17B10 Q99714 3/20 0.42
PKM P14618 2/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 3/20 0.41
ACLY P53396 1/20 0.40
NPC1 O15118 2/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP2D6 P10635 1/20 0.39
ACACA Q13085 1/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C9 P11712 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14848484 0.88 KDM4E (0.44) ALDH1A1HPGDKDM4EHSD17B10PKM
SCHEMBL14848497 0.82 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EHSD17B10PKM
SCHEMBL14848452 0.80 NOTUM (0.44) ALDH1A1HPGDKDM4EHSD17B10PKM
SCHEMBL14848457 0.79 ALDH1A1 (0.40) ALDH1A1HPGDHSD17B10PKMMEN1
SCHEMBL9550442 0.77 MAOA (0.51) ALDH1A1HPGDKDM4EPKMMEN1
SCHEMBL7103671 0.71 ACLY (0.56) ALDH1A1HPGDKDM4EPKMMEN1
SCHEMBL14848593 0.71 HPGD (0.47) ALDH1A1HPGDKDM4EPKMMEN1
SCHEMBL14097520 0.70 KDM4E (0.52) ALDH1A1HPGDKDM4EHSD17B10PKM
SCHEMBL7353766 0.70 KMT2A (0.51) KDM4EHTTKMT2ARAB9ACYP2D6
SCHEMBL1554320 0.70 KDM4E (0.53) ALDH1A1HPGDKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933075-B2 Compounds useful as antiviral agents, compositions, and methods of use FUZIANS BIOMEDICALS, INC. (KY) 2015-01-13 US disclosed
US-20130090339-A1 COMPOUNDS USEFUL AS ANTIVIRAL AGENTS, COMPOSITIONS, AND METHODS OF USE THE UAB RESEARCH FOUNDATION (US) 2013-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090339-A1 COMPOUNDS USEFUL AS ANTIVIRAL AGENTS, COMPOSITIONS, AND METHODS OF USE SAMHD1, ZC3HAV1, DDX5 ALDH1A1 3597/4885HPGD 3316/4885KDM4E 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.